Preventive effects of an extract of Erythrina lysistemon (Fabaceae) on some menopausal problems: Studies on the rat

Journal of Complementary and Integrative Medicine

Volumn 4, Issue 1, 2007, Pages

  Njamen, Dieudonné ^a   Magne Ndé, Chantal Béatrice ^a   Tanee Fomum, Zacharias ^a   Mbanya, Jean Claude ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Bone loss; Erythrina lysistemon; Glucose intolerance; Lipids; Menopausal status

Indexed keywords

ACETIC ACID ETHYL ESTER; ERYTHRINA EXTRACT; ERYTHRINA LYSISTEMON EXTRACT; ESTROGEN RECEPTOR; ESTRONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ERYTHRINA; ERYTHRINA LYSISTEMON; ESTROGEN ACTIVITY; EXPERIMENTAL MODEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; LEGUME; LIPID BLOOD LEVEL; MENOPAUSAL SYNDROME; MENOPAUSE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; RAT; VAGINA EPITHELIUM; WEIGHT GAIN;

EID: 34948905324     PISSN: 15533840     EISSN: None     Source Type: Journal    
DOI: 10.2202/1553-3840.1092     Document Type: Article

References (54)

1. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126: 43-50
2. Aurbach GD, Marx SJ, Spiegel AM. Metabolic bone disease. In Williams Textbook of Endocrinology, ed. JD Wilson, DW Foster. Philadelphia: Saunders. 8th ed.1992; 28: 1477-517.
3. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr 1996; 126: 161-67.
4. Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A, Tsai B, Hile K, Brown JW, Meldrum DR. The role of estrogen in cardiovascular disease. J Surg Res 2003; 115: 325-344.
5. Bertolotti M, Spady DK. Effect of hypocholesterolemic doses of 17 alphaethinyl estradiol on cholesterol balance in liver and extrahepatic tissues. J Lipid Res 1996; 37: 1812-1822.
6. Burroughs CD, Bern HA, Stokstad ELR. Prolonged vaginal cornification and other changes in mice treated neonatally with coumestrol, a plant estrogen. J Toxicol Environ Health 1985; 15:51-61.
7. Burroughs CD, Mills KT, Bern HA. Reproductive abnormalities in female mice exposed neonatally to various doses of coumestrol. J Toxicol Environ Health 1990; 30:105-22.
8. Burroughs CD, Mills KT, Bern HA. Long-term genital tract changes in female mice treated neonatally with coumestrol. Reprod Toxicol 1990; 4:127-35.
9. Cline JM, Hughes CLJr. Phytochemicals for the prevention of breast and environmental cancer. In: Cline JM, Hughes CL, Jr, Foon KA, et al, eds. Biological and hormonal therapies of cancer. Boston: Kluwer Academic Publishers, 1998; p107-134.
10. Cline JM, Paschold JC, Anthony MS, Obasanjo IO, Adams MR. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 1996; 65: 1031-5.
11. Cynthia K. Sites, Georgia D. L'Hommedieu, Michael J. Toth, Martin Brochu, Brian C. Cooper and Penny A. Fairhurst. The effect of Hormone Replacement Therapy on Body Composition, Body Fat Distribution, and Insulin Sensitivity in Menopausal Women: A Randomized, Double-Blind, Placebo-Control Trial. The Journal of Clinical Endocrinology and Metabolism 2005; 90 (5): 2701-07.
12. Deshaies Y, Dagnault A, Lalonde J, Richard D. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat. Am J Physiol Endocrinol Metab 1997; 273:E355-E62.
13. Dagnault A, Deshaies Y, Richard D. Involvement of type I corticosteroid receptor in the effects of ovariectomy on energy balance. Am J Physiol Regulatory Integrative Comp Physiol 1996; 270:R199-R206.
14. Diamanti-Kandarakis E. Hormone replacement therapy and risk of malignancy. Curr Opin Obstet Gynecol 2004; 6: 73-78.
15. Di Croce L, Bruscalupi G, Trentalance A. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. Biochem Biophys Res Commun 1996; 224: 345-350.
16. El-Masry S, Amer ME, Abdel-Kader MS, Zaatout HH. Prenylated flavonoids of Erythrina lysistemon grown in Egypt. Phytochemistry 2002; 60: 780-787.
17. El Samannoudy FA, Shareha AM, Ghannudi SA, Gillaly GA, El Mougy SA. Adverse effects of phytoestrogens - 7. Effect of ß-sitosterol treatment on follicular development, ovarian structure and uterus in the immature female sheep. Cell Mol Biol 1980; 26:255-66.
18. Erickson SK, Jaeckle S, Lear SR, Brady SM, Havel RJ. Regulation of hepatic cholesterol and lipoprotein metabolism in ethinyl estradiol-treated rats. J Lipid Res 1989; 30: 1763-1771.
19. Ettinger B. Prevention of osteoporosis: treatment of estradiol deficiency. Obstet. Gynecol 1988; 72: 12-17S
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
21. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001; 75: 898-915.
22. Gohlke-Barwolf C. Coronary artery disease - is menopause a risk factor? Basic Res Cardiol 2000; 95: I77-83.
23. Goodman-Gruen D, Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women: The Rancho Bernardo Study. Diabetes Care 1997; 20: 645-649.
24. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr 2001; 131: 1202-1206.
25. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest 1989; 19: 395-403.
26. Hertrampf T, Gruca MJ, Seibel J, Laudenbach U, Fritzemeier KH, Diel P. The bone-protective effect of the phytoestrogen genistein is mediated via Er9-dependent mechanisms and strongly enhanced by physical activity. Bone 2007; 40: 1529-1535.
27. Hughes CLJr, Kaldas RS, Weisinger AS, McCants CE, Basham KB. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomised rat: part 1. Reprod Toxicol 1991; 5:127-32.
28. Jacobs HS. Postmenopausal hormone replacement therapy and breast cancer. Medscape Womens Health 2000; 5: E2.
29. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002; 25:1709-1714.
30. Ju-Yuan Guo, Xiaosong Li, Jimmy D. Browning JDJr, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, MacDonald RS. Dietary Soy Isoflavones and Estrone Protect Ovariectomized ER9KO and Wild-Type Mice from Carcinogen-Induced Colon Cancer. J Nutr 2004; 134: 179-82.
31. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA and Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2003; 138: 1-9.
32. Kalu DN, Masoro EJ, Yu BP, Hardin RR, Hollic BW. Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 1988; 122: 1847-54
33. Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem 1979; 254: 11367-11373.
34. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J and Howard BV. Effect of oestrogen plus progestin on the incidence diabetes in postmenopausal wowen: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004; 47: 1175-87.
35. McClung MR. The menopause and HRT. Prevention and management of osteoporosis. Best Pract Res Clin Endocrinol Metab 2003; 17: 53-71.
36. McPherson R. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study. Can J Cardiol 2000; 16 Suppl A: 14A-19A.
37. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Noraha T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with oestrogen receptors alpha and beta. Biol Pharm Bull 2001; 24(4): 351-6.
38. Mindy S. Kurzer and Xia Xu. Dietary phytoestrogens. Annual Review of Nutrition 1997; 17: 353-381.
39. Parini P, Angelin B, Rudling M. Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol 1997; 17:1800-1805.
40. Preiss-Landl K, Zimmermann R, Hammerle G, Zechner R. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 2002; 13: 471-481.
41. Pino AM, Valladares LE, Palma MA, Mancilla AM, Yanez M & Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J. Clin. Endocrinol. Metab 2000; 85: 2797-2800.
42. Richard D. Effects of ovarian hormones on energy balance and brown adipose tissue thermogenesis. Am J Physiol Regulatory Integrative Comp Physiol 1986; 250:R245-R9.
43. Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 1999; 20: 269-277.
44. Simkin-Silverman LR, Wing RR. Weight gain during menopause. Is it inevitable or can it be prevented? Postgrad Med J 2000; 108:47-50.
45. Tanee FSF, Njamen D, Magne Ndé CB, Wandji J, Zierau O, Fomum ZT and Vollmer G. Estrogenic effects of the ethyl-acetate extract of the stem bark of Erythrina lysistemon Hutch (Fabaceae). Phytomedicine 2007; 14:222-226.
46. Tchernof A, Poehlman ET, Despres JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000; 26:12-20.
47. Umland EM, Cauffield JS, Kirk JK, Thomason TE. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy 2000; 20(8): 981-90.
48. Wade GN, Gray JM, Bartness TJ. Gonadal influences on adiposity. Int J Obes Relat Metab Disord 1985; 9:83-92.
49. Weyer C, Bogardus C, Mott DM and Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787-794.
50. World Health Organisation. Report of a WHO Scientific Group, Technical Report Series, No 866: Research on the menopause on 1990s. WHO 1996; 114p.
51. Whitten PL, Lewis C, Naftolin FA. Phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol Reprod 1993; 49:1117-21.
52. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. Jama 1995; 273: 461-465.
53. Windler EE, Kovanen PT, Chao YS, Brown MS, Havel RJ, Goldstein JL. The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. J Biol Chem 1980; 255: 10464-10471.
54. Yeung J, Yu TF. Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2003; 2:15.